Variables | p | OR | 95%CI |
---|---|---|---|
Time (months post-RT for NPC) | 0.012 | Â | Â |
3 months after RT | 0.025 | 0.318 | 0.117 ~ 0.865 |
6 months after RT | 0.052 | 0.367 | 0.134 ~ 1.009 |
9 months after RT | 0.455 | 0.662 | 0.225 ~ 1.953 |
12 months after RT | 0.296 | 0.551 | 0.181 ~ 1.684 |
18 months after RT | 0.878 | 1.100 | 0.324 ~ 3.738 |
24months after RT | 0.787 | 1.192 | 0.333 ~ 4.269 |
Age | 0.703 | 0.914 | 0.578 ~ 1.447 |
Gender | 0.141 | 0.701 | 0.437 ~ 1.125 |
Pathological type | 0.271 | 0.538 | 0.179 ~ 1.621 |
T-staging | 0.306 | Â | Â |
T2 | 0.557 | 1.221 | 0.627 ~ 2.377 |
T3 | 0.386 | 1.353 | 0.683 ~ 2.680 |
T4 | 0.380 | 0.689 | 0.300 ~ 1.584 |
 N-staging | 0.229 |  |  |
N2 | 0.241 | 1.641 | 0.717 ~ 3.759 |
N3 | 0.982 | 1.008 | 0.497 ~ 2.044 |
N4 | 0.513 | 0.770 | 0.352 ~ 1.686 |
M-staging | 0.114 | 0.526 | 0.237 ~ 1.167 |
TNM staging | 0.085 | Â | Â |
II | 0.591 | 1.439 | 0.381 ~ 5.432 |
III | 0.474 | 1.584 | 0.449 ~ 5.592 |
IV | 0.788 | 0.841 | 0.238 ~ 2.969 |
Smoking history | 0.000 | 2.806 | 1.651 ~ 4.771 |
Intranasal medication | 0.735 | 0.925 | 0.590 ~ 1.452 |
Nasal irrigation | 0.178 | 0.253 | 0.034 ~ 1.873 |
Radiotherapy modality | 0.279 | 1.282 | 0.818 ~ 2.011 |
Dose of primary lesions | 0.491 | 1.263 | 0.650 ~ 2.452 |
Chemotherapy modality | 0.480 | Â | Â |
Concurrent chemotherapy | 0.492 | 0.476 | 0.057 ~ 3.957 |
Induction & concurrent chemotherapy | 0.828 | 0.795 | 0.101 ~ 6.277 |
Induction & concurrent & adjuvant/consolidation chemotherapy | 0.762 | 0.726 | 0.091 ~ 5.773 |
Nasal cavity/paranasal sinus invasion | 0.816 | 1.095 | 0.509 ~ 2.357 |